文献速递肾小球疾病急性肾损伤

ANCA相关性肾小球肾炎中的单克隆丙种球蛋白病:患病率、特征与结局

Monoclonal gammopathy in ANCA-associated glomerulonephritis: prevalence, characteristics and outcomes.
PubMed 文献 · Nephrol Dial Transplant · 2026-08-18

这项多中心回顾性研究纳入332例ANCA相关性肾小球肾炎患者,诊断时单克隆丙种球蛋白病(MG)检出率为15.1%。单因素分析显示MG与总生存率降低、严重感染和癌症风险增加相关,但多因素校正后MG并非独立预测因素,且与肾脏特异性结局无关。研究提示MG应视为共存状况而非疾病修饰因素。

要点

  • ANCA相关性肾小球肾炎患者中MG检出率为15.1%,多见于老年男性及高血压患者。
  • 单因素分析MG与死亡、严重感染和癌症风险相关,但校正后非独立预测因素。
  • MG与ESRD、复发、心血管事件无关,随访期间无患者进展为多发性骨髓瘤。

核心结论

  • MG在ANCA-GN患者中常见,主要反映年龄和合并症,不独立影响肾脏生存、死亡率或血液系统恶性肿瘤进展。
  • MG应被视为共存状况而非疾病修饰因素,但仍需标准化随访。

研究设计与样本

  • 多中心回顾性研究,纳入7个中心共332例ANCA-GN患者。
  • 诊断时通过血清电泳和/或免疫固定电泳识别MG,比较MG阳性与阴性患者的临床、实验室和组织学特征。
  • 采用Kaplan-Meier分析和单因素及多因素Cox回归分析结局。

主要发现

  • 332例患者中位年龄65岁(56-75),男性占59%,MG检出50例(15.1%)。
  • MG阳性患者趋向年龄更大、男性更多、高血压更多、血清白蛋白更低,但肾功能、BVAS、ANCA亚型和组织学表现相似。
  • 中位随访57个月,单因素分析显示MG与总生存率降低(HR 2.19,CI 1.28-3.75,p=0.004)、严重感染风险增加(HR 1.76,CI 1.17-2.64,p=0.007)和癌症风险增加(HR 2.07,CI 1.08-3.95,p=0.028)相关。
  • 多因素校正后,MG不再是死亡率、感染或癌症的独立预测因素,且与ESRD等肾脏特异性结局无关。
  • 复发、心血管事件(MACE)或进展至ESRD无差异,随访期间无患者发生多发性骨髓瘤或相关血液系统恶性肿瘤。

临床怎么用

  • 对ANCA-GN患者诊断时可行血清电泳和/或免疫固定电泳筛查MG。
  • MG阳性提示需关注合并症和感染风险,但不应据此改变ANCA-GN的免疫抑制治疗决策。
  • MG阳性患者仍需标准化随访,监测血液系统异常,但无需过度担忧进展为多发性骨髓瘤。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • MG识别仅基于诊断时血清电泳和/或免疫固定电泳,未描述随访中MG的动态变化。
  • 随访期间未观察到多发性骨髓瘤发生,可能受随访时间限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monoclonal gammopathy (MG) is common in older individuals and may influence autoimmune diseases. Its impact in ANCA-associated glomerulonephritis (ANCA-GN) remains poorly evaluated. METHODS: We conducted a multicenter retrospective study including 332 patients with ANCA-GN from 7 centers. MG was identified at diagnosis by serum electrophoresis and/or immunofixation. Clinical, laboratory, and histological characteristics were compared according to MG status. Outcomes including end-stage renal disease (ESRD), relapse, major cardiovascular events (MACE), severe infections, cancer, and mortality were analyzed using Kaplan-Meier analysis and factors associated with outcomes were studied using univariable and multivariable Cox regression. RESULTS: Among 332 patients (median age 65 years [56-75], 59% males), MG was detected in 50 patients (15.1%). MG-positive patients tended to be older, were more frequently males, had more hypertension, and lower serum albumin levels, but similar renal function, BVAS, ANCA subtype, and histological findings compared with MG-negative patients. During a median follow-up of 57 months, MG was associated with reduced overall survival (HR 2.19, CI 1.28-3.75, p = 0.004), an increased risk of severe infections (HR 1.76, CI 1.17-2.64, p = 0.007) and an increased risk of cancer (HR 2.07, CI 1.08-3.95, p = 0.028) in univariable analyses. However, after adjustment, MG was no longer an independent predictor of mortality, infection or cancer, and was not associated with kidney-specific outcomes such as ESRD. No differences were observed for relapse, cardiovascular events (MACE), or progression to ESRD. Importantly, no patient developed multiple myeloma or related hematological malignancies during follow-up. CONCLUSIONS: MG is frequent in patients with ANCA-GN, mainly reflecting age and comorbidity but does not independently influence renal survival, mortality, or progression to hematological malignancy. MG should be considered a coexisting condition rather than a disease modifier in ANCA-GN, although standardized follow-up remains warranted.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Desouche A, Garnier AS, Coindre JP, et al. Monoclonal gammopathy in ANCA-associated glomerulonephritis: prevalence, characteristics and outcomes. Nephrol Dial Transplant. 2026. PMID: 42610751. doi:10.1093/ndt/gfag174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。